{
    "organizations": [],
    "uuid": "ddcb242ddf86df49e83f40a55e9589c115ac18a1",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-biophytis-receives-orphan-drug-des/brief-biophytis-receives-orphan-drug-designation-in-u-s-for-sarconeos-in-dmd-idUSFWN1SM1BJ",
    "ord_in_thread": 0,
    "title": "BRIEF-Biophytis Receives Orphan Drug Designation In U.S. For Sarconeos In DMD",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 15 (Reuters) - Biophytis SA:\n* BIOPHYTIS RECEIVES ORPHAN DRUG DESIGNATION IN THE UNITED STATES FOR SARCONEOS IN DUCHENNE MUSCULAR DYSTROPHY (DMD)\n* BIOPHYTIS SA - HAS ALSO FILED AN APPLICATION FOR AN ORPHAN DRUG DESIGNATION FOR SARCONEOS IN DUCHENNE MYOPATHY WITH EMA Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles. ",
    "published": "2018-05-16T03:31:00.000+03:00",
    "crawled": "2018-05-16T19:21:33.078+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "biophytis",
        "sa",
        "biophytis",
        "receives",
        "orphan",
        "drug",
        "designation",
        "united",
        "state",
        "sarconeos",
        "duchenne",
        "muscular",
        "dystrophy",
        "dmd",
        "biophytis",
        "sa",
        "also",
        "filed",
        "application",
        "orphan",
        "drug",
        "designation",
        "sarconeos",
        "duchenne",
        "myopathy",
        "ema",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}